nach oben

Journal of Urban Health

Erschienen in:

05.06.2019

Overdose Prevention Site Acceptability among Residents and Businesses Surrounding a Proposed Site in Philadelphia, USA

verfasst von: Alexis M. Roth, Alex H. Kral, Allison Mitchell, Rohit Mukherjee, Peter Davidson, Stephen E. Lankenau

Erschienen in: Journal of Urban Health | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Overdose prevention sites (OPS) are places where people use previously obtained drugs under the supervision of a health professional. They have been proposed in six United States (US) cities, including Philadelphia, to help reduce opioid-related overdose deaths and public injection. Philadelphia has the highest overdose rate among large cities in the US, which has led a local community-based organization to plan the implementation of OPS. Kensington, a neighborhood with the highest drug mortality overdose rates in the city, is a likely site for the proposed OPS. Given the dearth of research systematically assessing public opinion towards OPS prior to implementation, we enrolled 360 residents and 79 business owners/staff in the Kensington neighborhood in a cross-sectional acceptability study. Face-to-face surveys assessed participant characteristics, experiences with drug-related social problems, and OPS acceptability. Using descriptive statistics, we estimated factors associated with favorability towards opening an OPS in the Kensington neighborhood. Ninety percent of residents were in favor of an OPS opening in Kensington. Support was significantly higher among unstably housed individuals and persons who currently use opioids. In the business sample, 63% of owners/staff were in favor of opening an OPS in Kensington. A greater proportion of Asian/Pacific Islanders, Hispanic/Latinx respondents, and non-Hispanic/Latinx Black respondents were in favor of an OPS opening in Kensington compared with white respondents (p < 0.04). While details about implementation are still being considered, results indicate general acceptability among Kensington residents and businesses for an OPS, especially if it can deliver benefits that curb drug-related social problems. Should an OPS be implemented in Philadelphia, it would be important to monitor changes in drug-related social problems and acceptability post implementation.

During the data collection period for this paper, “Kensington” was popularly used to refer to the adjoining Kensington and Harrowgate neighborhoods [5].

Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths - United States, 2013-2017. MMWR Morb Mortal Wkly Rep. 2018;67(5152):1419–27.CrossRefPubMedPubMedCentral

Opioid misuse and overdose data. City of Philadelphia opioid surveillance dashboard web site. https://www.phila.gov/programs/combating-the-opioid-epidemic/reports-and-data/opioid-misuse-and-overdose-data/. Revised November 19, 2018. Accessed April 2, 2019.

Farley T. CHART: fatal drug overdoses in Philadelphia, 2017. Philadelphia Department of Public Health. https://www.phila.gov/media/20180912140436/chart-v3e1.pdf. Published April 2018. Accessed April 3, 2019.

Philadelphia Department of Public Health Opioid Program. Incidence of overdose deaths in Philadelphia by zip code, 2017. https://public.tableau.com/profile/pdph#!/vizhome/UnintentionalDrugRelatedDeaths/UnintentionalDrugRelatedDeaths. Revised November 20, 2018. Accessed April 3, 2019.

Marin M. ‘Where’s Harrowgate?’ a Philadelphia neighborhood tries to reclaim its name. Billy Penn. 2019. https://billypenn.com/2019/02/17/wheres-harrowgate-a-philadelphia-neighborhood-tries-to-reclaim-its-name/. Accessed April 15, 2019.

MacDonald T. Homeless increase in Kensington has city counselwoman angrily calling for answers. WHYY. 2018. https://whyy.org/articles/homeless-increase-in-kensington-has-city-councilwoman-angrily-calling-for-answers/. Accessed April 2, 2019.

Barry, C., Sherman, S., & McGinty, E. (2018). Language matters in combatting the opioid epidemic: Safe consumption sites versus overdose prevention sites. American Journal of Public Health, 108(9), 1157–1159. https://doi.org/10.2105/AJPH.2018.304588

Collins AB, Bluthenthal RN, Boyd J, McNeil R. Harnessing the language of overdose prevention to advance evidence-based responses to the opioid crisis. Int J Drug Policy. 2018;55:77–9.CrossRefPubMedPubMedCentral

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Drug consumption rooms: an overview of provision and evidence. http://www.emcdda.europa.eu/system/files/publications/2734/POD_Drug consumption rooms.pdf. Revised July 6, 2018. Accessed April 2, 2019.

10.

Potier C, Laprévote V, Dubois-Arber F, Cottencin O, Rolland B. Supervised injection services: what has been demonstrated? A systematic literature review. Drug Alcohol Depend. 2014;145:48–68.CrossRefPubMed

11.

Kennedy MC, Boyd J, Mayer S, Collins A, Kerr T, McNeil R. Peer worker involvement in low-threshold supervised consumption facilities in the context of an overdose epidemic in Vancouver, Canada. Soc Sci Med. 2019;225:60–8.CrossRefPubMed

12.

Haemmig R, van Beek I. Supervised injecting rooms. In: Pates R, McBride A, Arnold K, editors. Injecting illicit drugs. Oxford: Blackwell Publishing; 2005.

13.

Supervised consumption services. The drug policy alliance web site. http://www.drugpolicy.org/resource/supervised-consumption-services. Published August 6, 2018. Accessed April 5, 2019.

14.

Wood E, Tyndall MW, Zhang R, Montaner JSG, Kerr T. Rate of detoxification service use and its impact among a cohort of supervised injecting facility users. Addiction. 2007;102(6):916–9.CrossRefPubMed

15.

Wood E, Kerr T, Small W, Li K, Marsh DC, Montaner JS, et al. Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. Can Med Assoc J. 2004;171(7):731–4.CrossRef

16.

Pinkerton SD. How many HIV infections are prevented by Vancouver Canada’s supervised injection facility? Int J Drug Policy. 2011;22(3):179–83. https://doi.org/10.1016/j.drugpo.2011.03.003.CrossRefPubMed

17.

McNeil R, Small W. ‘Safer environment interventions’: a qualitative synthesis of the experiences and perceptions of people who inject drugs. Soc Sci Med. 2014;106:151–8.CrossRefPubMedPubMedCentral

18.

Davidson PJ, Lopez AM, Kral AH. Using drugs in un/safe spaces: impact of perceived illegality on an underground supervised injecting facility in the United States. Int J Drug Policy. 2018;53:37–44.CrossRefPubMed

19.

Barry CL, Sherman SG, Stone E, et al. Arguments supporting and opposing legalization of safe consumption sites in the U.S. Int J Drug Policy. 2019;63:18–22.

20.

Kral AH, Davidson PJ. Addressing the nation’s opioid epidemic: lessons from an unsanctioned supervised injection site in the U.S. Am J Prev Med. 2017;53(6):919–22.CrossRefPubMed

21.

McGinty EE, Barry CL, Stone EM, et al. Public support for safe consumption sites and syringe services programs to combat the opioid epidemic. Prev Med. 2018;111:73–7.CrossRefPubMed

22.

Cruz MF, Patra J, Fischer B, Rehm J, Kalousek K. Public opinion towards supervised injection facilities and heroin-assisted treatment in Ontario, Canada. Int J Drug Policy. 2007;18(1):54–61.CrossRefPubMed

23.

Bardwell G, Scheim A, Mitra S, Kerr T. Assessing support for supervised injection services among community stakeholders in London, Canada. Int J Drug Policy. 2017;48:27–33.CrossRefPubMed

24.

Thein H-H, Kimber J, Maher L, MacDonald M, Kaldor JM. Public opinion towards supervised injecting centres and the Sydney Medically Supervised Injecting Centre. Int J Drug Policy. 2005;16(4):275–80.CrossRef

25.

Salmon AM, Thein H-H, Kimber J, Kaldor JM, Maher L. Five years on: what are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre? Int J Drug Policy. 2007;18(1):46–53.CrossRefPubMed

26.

Lange BCL, Bach-Mortensen AM. A systematic review of stakeholder perceptions of supervised injection facilities. Drug Alcohol Depend. 2019;197:299–314.CrossRefPubMed

27.

Wiebe D, Solomon, S. Cues location: a community-informed approach. University of Pennsylvania Injury Science Center. Published 2018. https://docs.wixstatic.com/ugd/eabb1f_00975a35a6a3425dbc24fd75a75fa621.pdf. Accessed April 9, 2019.

28.

Marin M. Where will Safehouse open a supervised injection site? Study tags potential locations. Billy Penn. 2019. https://billypenn.com/2019/03/10/where-will-safehouse-open-a-supervised-injection-site-study-tags-potential-locations/. Accessed April 3, 2019.

29.

Harris RE, Richardson J, Frasso R, Anderson ED. Perceptions about supervised injection facilities among people who inject drugs in Philadelphia. Int J Drug Policy. 2018;52:56–61.CrossRefPubMed

30.

Jones S. Where were safe spaces when black and brown people were addicted to crack? The Inquirer. 2018. https://www.philly.com/philly/columnists/solomon_jones/safe-injection-sites-philadelphia-crack-cocaine-race-20180131.html. Accessed April 3, 2019.

31.

Bond CH. Kensington forum on opioids packs the house, but avoids fiery debate. Billy Penn. 2018. https://billypenn.com/2018/03/28/kensington-forum-on-opioids-packs-the-house-but-avoids-fiery-debate/. Accessed April 4, 2019

32.

Marin M. Supervised injection site in Kensington might not be permenant, founders say, as opposition floods meeting. Billy Penn. 2019. https://billypenn.com/2019/04/05/supervised-injection-site-in-kensington-might-not-be-permanent-founders-say/. Accessed April 6, 2019.

33.

Steele A. In Philadelphia’s Harrowgate section, diverse food scene emerges, with coffee, beer, bakeries, and more. The Inquirer. 2019. https://www.philly.com/food/harrowgate-ca-phe-vietnamese-coffee-sacred-vice-brewing-fishtown-ferments-maken-20190409.html. Accessed April 11, 2019

34.

Jozaghi E. The role of drug users’ advocacy group in changing the dynamics of life in the Downtown Eastside of Vancouver, Canada. J Subst Abus. 2014;19(1–2):213–8.

35.

Allyn B. Rendell says Philly group near deal on home for supervised injection site. WITF 2019. https://www.witf.org/news/2019/03/rendell-says-philly-group-near-deal-on-home-for-supervised-injection-site.php. Accessed April 4, 2019.

36.

Deeney J. Philadelphia’s Kensington ave: heroin, prostitution, and no police. The Daily Beast. August 13, 2011. https://www.thedailybeast.com/philadelphias-kensington-avenue-heroin-prostitution-and-no-police. Accessed April 4, 2019.

37.

U.S. Department of Justice National Drug Intelligence Center. Philadelphia/Camden high intensity drug trafficking area drug market analysis 2011. https://www.justice.gov/archive/ndic/dmas/Philadelphia-Camden_DMA-2011(U).pdf. Published September 2011. Accessed April 3, 2019.

38.

Eichel, L. Crime, drugs, public safety are the issues that matter most to Philadelphians in 2019. The PEW Charitable Trusts. Published May 2019. Accessed May 9, 2019

39.

Lai, J., Vargas, C., & Terruso, J. Inquirer poll: What Philly voters think of Mayor Jim Kenney, crime, and the soda tax. The Inquirer. April 29, 2019. Accessed May 9, 2019.

40.

Kral AH, Wenger L, Carpenter L, Wood E, Kerr T, Bourgois P. Acceptability of a safer injection facility among injection drug users in San Francisco. Drug Alcohol Depend. 2010;110(1):160–3.CrossRefPubMedPubMedCentral

41.

Bouvier BA, Elston B, Hadland SE, Green TC, Marshall BDL. Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study. Harm Reduct J. 2017;14(1):1–9.CrossRef

42.

Fry C, Fox S, Rumbold G. Establishing safe injecting rooms in Australia: attitudes of injecting drug users. Aust N Z J Public Health. 1999;23(5):501–4. https://doi.org/10.1111/j.1467-842X.1999.tb01306.x.CrossRefPubMed

43.

Wenger LD, Arreola SG, Kral AH. The prospect of implementing a safer injection facility in San Francisco: perspectives of community stakeholders. Int J Drug Policy. 2011;22(3):239–41.CrossRefPubMed

44.

Miller KW, Wilder LB, Stillman FA, Becker DM. The feasibility of a street-intercept survey method in an African-American community. Am J Public Health. 1997;87(4):655–8.CrossRefPubMedPubMedCentral

45.

Lankenau S, Teti M, Silva K, Jackson Bloom J, Harocopos A, Tresse M. Patterns of prescription drug misuse among young injection drug users. J Urban Health. 2012;89:1004–16.CrossRefPubMedPubMedCentral

46.

Lankenau S, Wagner K, Silva K, Kecojevic A, Iverson E, McNeely M, et al. Injection drug users trained by overdose prevention programs: responses to witnessed overdoses. J Community Health. 2013;38:133–41.CrossRefPubMedPubMedCentral

Titel: Overdose Prevention Site Acceptability among Residents and Businesses Surrounding a Proposed Site in Philadelphia, USA
verfasst von: Alexis M. Roth
Alex H. Kral
Allison Mitchell
Rohit Mukherjee
Peter Davidson
Stephen E. Lankenau
Publikationsdatum: 05.06.2019
Verlag: Springer US
Erschienen in: Journal of Urban Health / Ausgabe 3/2019
Print ISSN: 1099-3460
Elektronische ISSN: 1468-2869
DOI: https://doi.org/10.1007/s11524-019-00364-2

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2019

Expanding a Comprehensive Strategy for Overdose Prevention in the USA

Beliefs Associated with Pharmacy-Based Naloxone: a Qualitative Study of Pharmacy-Based Naloxone Purchasers and People at Risk for Opioid Overdose

Willingness to Use Safe Consumption Spaces among Opioid Users at High Risk of Fentanyl Overdose in Baltimore, Providence, and Boston

Transactional Sex among Men Who Have Sex with Men: Differences by Substance Use and HIV Status

Greenspace and Infant Mortality in Philadelphia, PA

Syndemic and Synergistic Effects of Intimate Partner Violence, Crystal Methamphetamine, and Depression on HIV Sexual Risk Behaviors among Women Who Inject Drugs in Indonesia